Feasibility of a Smartphone App with Mindfulness Training for Adolescent Smoking Cessation: Craving to Quit (C2Q)-Teen
Authors
Pbert, LoriDruker, Susan
Crawford, Sybil L.
Frisard, Christine
Trivedi, Michelle
Osganian, Stavroula K.
Brewer, Judson
UMass Chan Affiliations
Prevention Research CenterDepartmetn of Pediatrics, Division of Pediatric Pulmonology
Graduate School of Nursing
Department of Population and Quantitative Health Sciences, Division of Preventive and Behavioral Medicine
Document Type
Journal ArticlePublication Date
2020-03-01Keywords
AdolescentsApp delivery
Mindfulness training
Randomized controlled trial
Smoking cessation
Alternative and Complementary Medicine
Communication Technology and New Media
Health Communication
Health Services Administration
Movement and Mind-Body Therapies
Nursing
Substance Abuse and Addiction
Telemedicine
UMCCTS funding
Metadata
Show full item recordAbstract
Objectives: The use of mobile technology for smoking cessation holds promise for adolescents, who do not typically access traditional treatments, but most are not grounded in theory or mechanism. Operant conditioning theory suggests an addictive smoking loop is formed between nicotine use and affective states, leading to habitual cue-induced craving and automatic behavior; mindfulness training may bring automated smoking behavior into awareness, so smokers may work mindfully with cravings. Mindfulness training delivered via smartphone technology therefore has potential to help adolescent smokers break this addictive loop and quit smoking. This pair-matched cluster-randomized controlled school-based pilot study evaluated program feasibility and preliminary smoking outcomes in relation to intervention engagement. Methods: Six high schools were pair matched and randomly assigned to one of three interventions: (1) mindfulness training delivered via mobile smoking cessation application (Craving to Quit, C2Q), (2) NCI's QuitSTART smoking cessation application (NCI), and (3) written cessation materials (Materials). Adolescents (n = 146) smoking 5 or more cigarettes per day were recruited. Interventions were implemented over four weeks and study assessments were collected at baseline and 3- and 6- month follow-up, including self-reported 7-day point prevalence abstinence, program usage, smoking-related measures, and psychosocial factors. Results: Overall cotinine-validated abstinence at 6 months was 15.8% and was similar between conditions. Odds of abstinence increased with each quartile increase in app/materials use with no significant differences between conditions (OR=1.60 (C2Q), 1.66 (Materials), and 2.69 (NCI)). Of participants still smoking at 6 months, for each quartile increase in engagement the number of cigarettes smoked in the previous 7 days showed a significantly greater decline in the C2Q condition (-5.71) compared to the Materials (-0.95) and NCI (+7.73) condition (p=0.02 for differences between conditions). Conclusions: Cotinine-validated abstinence was similar between intervention conditions and tended to increase with greater engagement in each condition. Greater C2Q app engagement among continuing smokers was associated with a significantly greater decline in number of cigarettes smoked compared to the other conditions. The Craving to Quit (C2Q) mobile smoking cessation application with mindfulness training was feasible to use and has promise in assisting adolescents to quit or decrease cigarette smoking. Clinical Trial Registration: Developing a Smartphone App with Mindfulness Training for Teen Smoking Cessation: ClinicalTrials.gov Identifier: NCT02218281.Source
Pbert L, Druker S, Crawford S, Frisard C, Trivedi M, Osganian SK, Brewer J. Feasibility of a Smartphone App with Mindfulness Training for Adolescent Smoking Cessation: Craving to Quit (C2Q)-Teen. Mindfulness (N Y). 2020 Mar;11(3):720-733. doi: 10.1007/s12671-019-01273-w. Epub 2019 Dec 20. PMID: 33343761; PMCID: PMC7747804. Link to article on publisher's site
DOI
10.1007/s12671-019-01273-wPermanent Link to this Item
http://hdl.handle.net/20.500.14038/34480PubMed ID
33343761Related Resources
ae974a485f413a2113503eed53cd6c53
10.1007/s12671-019-01273-w